Literature DB >> 11021398

Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin.

J Yoshimoto1, M Kakui, H Iwasaki, H Sugimoto, T Fujiwara, N Hattori.   

Abstract

We have recently described a novel hemagglutinin (HA) conformational change inhibitor of human influenza virus, Stachyflin (Yoshimoto et al, Arch. Virol., 144, 1-14, 1999). Stachyflin-resistant variants of human influenza A/WSN/33 (H1N1) virus were isolated in vitro and the nucleotide sequences of their HA genes were determined. The relation of amino acid substitutions and Stachyflin resistance was analyzed with in vitro membrane fusion between HA-expressing cells and octadecylrhodamine (R18)-labelled chick erythrocytes (RBC). The amino acid substitutions, lysine to arginine at position 51 or lysine to glutamic acid at position 121 of the HA2 subunit of the HA protein was enough to confer a Stachyflin-resistant phenotype of HA protein. The molecular mechanism of anti-HA conformational change activity of Stachyflin is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021398     DOI: 10.1111/j.1348-0421.2000.tb02549.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  12 in total

1.  New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.

Authors:  Arnab Basu; Aleksandar Antanasijevic; Minxiu Wang; Bing Li; Debra M Mills; Jessica A Ames; Peter J Nash; John D Williams; Norton P Peet; Donald T Moir; Mark N Prichard; Kathy A Keith; Dale L Barnard; Michael Caffrey; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

2.  Novel hemagglutinin-based influenza virus inhibitors.

Authors:  Xintian Shen; Xuanxuan Zhang; Shuwen Liu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

3.  Characterization of potent fusion inhibitors of influenza virus.

Authors:  Michael Rowse; Shihong Qiu; Jun Tsao; Tongmei Xian; Sarah Khawaja; Yohei Yamauchi; Zhen Yang; Guoxin Wang; Ming Luo
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 4.  Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.

Authors:  Shibo Jiang; Runming Li; Lanying Du; Shuwen Liu
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

5.  Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.

Authors:  Wenjiao Wu; Richan Li; Xianglian Li; Jian He; Shibo Jiang; Shuwen Liu; Jie Yang
Journal:  Viruses       Date:  2015-12-25       Impact factor: 5.048

Review 6.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

Review 7.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

8.  Protein-sol pKa: prediction of electrostatic frustration, with application to coronaviruses.

Authors:  Max Hebditch; Jim Warwicker
Journal:  Bioinformatics       Date:  2020-12-22       Impact factor: 6.937

Review 9.  Influenza A virus entry inhibitors targeting the hemagglutinin.

Authors:  Jie Yang; Minmin Li; Xintian Shen; Shuwen Liu
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

10.  Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.

Authors:  Yurie Motohashi; Manabu Igarashi; Masatoshi Okamatsu; Takeshi Noshi; Yoshihiro Sakoda; Naoki Yamamoto; Kimihito Ito; Ryu Yoshida; Hiroshi Kida
Journal:  Virol J       Date:  2013-04-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.